MENDLEIN JOHN

CIK 00012383627 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001238362

Recent Transactions

50 trades

Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2025-05-29+55,000→ 55,000 total
Award
Omega Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-20+25,000→ 25,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2024-06-07+40,000→ 40,000 total
Award
Omega Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-07+18,118→ 18,118 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-06-06+40,000→ 40,000 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Common Stock
2023-01-19$1.37/sh+28,461→ 311,231 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-01-19+28,461→ 0 total
Purchase
FATE THERAPEUTICS INC$FATE
Common Stock
2023-01-13$5.43/sh+36,631→ 282,770 total
Purchase
FATE THERAPEUTICS INC$FATE
Common Stock
2023-01-11$5.67/sh+88,048→ 246,139 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-09+8,650→ 166,741 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-06-09+11,893→ 11,893 total
Award
Omega Therapeutics, Inc.
Option (Right to Buy)
2022-06-08+18,118→ 18,118 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-03$22.79/sh−1,364→ 158,091 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-03-10$34.73/sh−19,493→ 171,524 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Common Stock
2022-03-10$1.63/sh+31,562→ 191,017 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-03-10−31,562→ 0 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-03-10$35.48/sh−12,069→ 159,455 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-06-02+4,334→ 4,334 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2021-06-02+2,681→ 159,455 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2020-05-01+16,000→ 16,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2019-05-08+20,000→ 20,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2019-05-03+16,000→ 16,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-12-21$0.42/sh+195,000→ 615,382 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2018-12-20$0.41/sh+50,000→ 420,382 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2018-05-15+20,000→ 20,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2018-05-02+16,000→ 16,000 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2018-01-02+32,000→ 32,000 total
Purchase
aTYR PHARMA INC$ATYR
Warrant to Purchase Common Stock
2017-08-31+14,151→ 14,151 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2017-08-31$2.65/sh+37,736→ 367,883 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2017-06-15+11,538→ 11,538 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2017-05-02+25,000→ 25,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2017-04-24$3.00/sh+124→ 327,647 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2017-04-20$3.00/sh+1,552→ 327,523 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2017-04-18$3.00/sh+1,000→ 325,971 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2017-02-07+185,000→ 185,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2016-12-19$2.20/sh+69,000→ 324,971 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2016-05-11+25,000→ 25,000 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2016-04-05$3.52/sh+2,500→ 250,971 total
Purchase
aTYR PHARMA INC$ATYR
Common Stock
2016-04-05$3.55/sh+2,500→ 248,471 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2016-02-03+96,153→ 96,153 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2016-01-27+135,000→ 135,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2016-01-04+148,732→ 148,732 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2015-10-01+71,000→ 71,000 total
Award
aTYR PHARMA INC$ATYR
Employee Stock Option (right to buy)
2015-10-01+65,070→ 65,070 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy
2015-05-13+10,000→ 10,000 total
Conversion
aTYR PHARMA INC$ATYR
Common Stock
2015-05-12+24,055→ 245,971 total
Conversion
aTYR PHARMA INC$ATYR
Series C Redeemable Convertible Preferred Stock
2015-05-12−170,218→ 0 total
Conversion
aTYR PHARMA INC$ATYR
Series D Redeemable Convertible Preferred Stock
2015-05-12−21,122→ 0 total
Award
aTYR PHARMA INC$ATYR
Stock Option (right to buy)
2015-05-06+163,437→ 163,437 total
Purchase
FATE THERAPEUTICS INC$FATE
Common Stock
2013-10-04$6.00/sh+16,667→ 156,774 total

MENDLEIN JOHN

Recent Transactions

Companies

Recent Filings

Address